A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum

Part of paid clinical trials in Lutherville, Maryland.

Sponsor
BioSensics
Study ID
NCT07569367
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Corticobasal Degeneration
  • Corticobasal Syndrome (CBS)
  • Frontotemporal Dementia (FTD)
  • Frontotemporal Lobar Degeneration (FTLD)

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with frontotemporal lobar degeneration (FTLD) syndromes. Researchers at BioSensics, Johns Hopkins University School of Medicine, and Massachusetts General Hospital will use wearable sensors, computerized speech, psychomotor, and cognitive assessments to create outcome measures and digital biomarkers for FTLD syndromes. Researchers will deploy this digital health solution to monitor 60 patients with FTLD syndromes for 24 months with study visits every 6 months.

Key Dates

Start date
Aug 1, 2026
Status verified
Apr 2026
Primary completion
Aug 15, 2030
Completion
Dec 15, 2030

Study Design

Enrollment
60 participants (estimated)

Arms

  • Arm: Frontotemporal Lobar Degeneration (FTLD)
    60 patients who have a clinical diagnosis of possible or probable FTLD syndrome phenotype.

Primary Outcome Measure

Physical Activity Monitoring [ Time Frame: 24 months ]

Locations (2)

FacilityCityStateZIPSite coordinators
Johns Hopkins University School of MedicineLuthervilleMaryland21093
Claudia Waddell
[email protected]
410-502-3290
Alexander Pantelyat, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Jesse Wang
[email protected]
617-643-2400
Anne-Marie Wills, MD,MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Lutherville, MD

By research site
Johns Hopkins University School of Medicine· Lutherville, MDMassachusetts General Hospital· Boston, MA

Related Studies